• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

催产素血浆水平可预测心理治疗的结果:慢性抑郁症的初步研究。

Oxytocin plasma levels predict the outcome of psychotherapy: A pilot study in chronic depression.

机构信息

Department of Psychiatry und Psychotherapy, Ludwig Maximilian University, Munich, Germany.

Department of Psychiatry und Psychotherapy, Ludwig Maximilian University, Munich, Germany; Hochschule Fresenius, University of Applied Sciences, Munich, Germany.

出版信息

J Affect Disord. 2018 Feb;227:206-213. doi: 10.1016/j.jad.2017.10.037. Epub 2017 Oct 24.

DOI:10.1016/j.jad.2017.10.037
PMID:29100154
Abstract

BACKGROUND

Oxytocin is associated with bonding and social deficits in psychiatric disorders and has also been discussed as a potential therapeutic intervention to augment psychotherapy. The Cognitive Behavioral Analysis System of Psychotherapy (CBASP) is a specific form of psychotherapy for chronic depression, an illness in which interpersonal deficits play a major role. In this pilot study, we investigated whether Oxytocin plasma levels predict the clinical outcome of chronic depressive patients after CBASP.

METHODS

Sixteen patients with chronic depression participated in a 10-week CBASP inpatient program. Oxytocin plasma levels were measured before and after participants played a virtual ball-tossing game (Cyberball) that mimics social exclusion. Clinical outcome after CBASP was evaluated with the Beck Depression Inventory-II (BDI-II) and the 24-item Hamilton Depression Rating Scale (HAMD-24).

RESULTS

After CBASP, depressive symptoms decreased significantly: the response rates were 44% (BDI-II) and 50% (HAMD-24); and the remission rates, 38% (BDI-II) and 44% (HAMD-24). Lower oxytocin plasma levels at baseline correlated with smaller changes in BDI-II scores, but not with the change in HAMD-24 scores.

LIMITATIONS

The limitations of our study were the small sample size, concomitant and non-standardized pharmacotherapy, and lack of a controlled design and a follow-up period.

CONCLUSIONS

Our study provides first evidence that oxytocin plasma levels may predict the outcome of psychotherapy in chronic depression. These findings need to be replicated in larger randomized, controlled trials.

摘要

背景

催产素与精神疾病中的联系和社交缺陷有关,也被讨论为增强心理治疗的潜在治疗干预措施。认知行为分析系统疗法(CBASP)是一种针对慢性抑郁症的特定形式的心理治疗,人际缺陷在这种疾病中起着重要作用。在这项初步研究中,我们调查了催产素血浆水平是否可以预测慢性抑郁症患者接受 CBASP 后的临床结果。

方法

16 名慢性抑郁症患者参加了为期 10 周的 CBASP 住院计划。在参与者玩模仿社交排斥的虚拟投球游戏(Cyberball)之前和之后,测量了催产素血浆水平。CBASP 后的临床结果用贝克抑郁量表第二版(BDI-II)和 24 项汉密尔顿抑郁量表(HAMD-24)进行评估。

结果

接受 CBASP 后,抑郁症状明显减轻:反应率分别为 44%(BDI-II)和 50%(HAMD-24);缓解率分别为 38%(BDI-II)和 44%(HAMD-24)。基线时催产素血浆水平较低与 BDI-II 评分的变化较小相关,但与 HAMD-24 评分的变化无关。

局限性

我们研究的局限性在于样本量小、同时进行的非标准化药物治疗以及缺乏对照设计和随访期。

结论

我们的研究首次提供了证据,表明催产素血浆水平可能预测慢性抑郁症心理治疗的结果。这些发现需要在更大的随机对照试验中得到复制。

相似文献

1
Oxytocin plasma levels predict the outcome of psychotherapy: A pilot study in chronic depression.催产素血浆水平可预测心理治疗的结果:慢性抑郁症的初步研究。
J Affect Disord. 2018 Feb;227:206-213. doi: 10.1016/j.jad.2017.10.037. Epub 2017 Oct 24.
2
Cognitive Behavioral Analysis System of Psychotherapy as group psychotherapy for chronically depressed inpatients: a naturalistic multicenter feasibility trial.认知行为分析系统心理治疗作为慢性住院抑郁症患者的团体心理治疗:一项自然主义多中心可行性试验。
Eur Arch Psychiatry Clin Neurosci. 2018 Dec;268(8):783-796. doi: 10.1007/s00406-017-0843-5. Epub 2017 Sep 27.
3
Effects of social exclusion on emotions and oxytocin and cortisol levels in patients with chronic depression.社会排斥对慢性抑郁症患者情绪及催产素和皮质醇水平的影响。
J Psychiatr Res. 2015 Jan;60:170-7. doi: 10.1016/j.jpsychires.2014.11.001. Epub 2014 Nov 10.
4
Two-Year Follow-Up after Treatment with the Cognitive Behavioral Analysis System of Psychotherapy versus Supportive Psychotherapy for Early-Onset Chronic Depression.认知行为分析系统心理治疗与支持性心理治疗治疗早发性慢性抑郁症的两年随访结果。
Psychother Psychosom. 2019;88(3):154-164. doi: 10.1159/000500189. Epub 2019 May 23.
5
A randomized controlled trial on the efficacy of mindfulness-based cognitive therapy and a group version of cognitive behavioral analysis system of psychotherapy for chronically depressed patients.一项关于正念认知疗法和团体版认知行为分析心理治疗系统对慢性抑郁症患者疗效的随机对照试验。
J Consult Clin Psychol. 2015 Oct;83(5):951-63. doi: 10.1037/ccp0000042. Epub 2015 Aug 10.
6
Patients' interpersonal problems as moderators of depression outcomes in a randomized controlled trial comparing mindfulness-based cognitive therapy and a group version of the cognitive-behavioral analysis system of psychotherapy in chronic depression.患者人际问题在正念认知疗法和认知行为分析系统团体版治疗慢性抑郁症的随机对照试验中作为抑郁结局的调节变量。
J Clin Psychol. 2020 Jul;76(7):1241-1254. doi: 10.1002/jclp.22931. Epub 2020 Jan 30.
7
Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.慢性抑郁症:当药物治疗(奈法唑酮)无效时,心理治疗(CBASP)有效;反之亦然。
Arch Gen Psychiatry. 2005 May;62(5):513-20. doi: 10.1001/archpsyc.62.5.513.
8
Group Cognitive Behavioural Analysis System of Psychotherapy (CBASP) for persistently depressed outpatients: a retrospective chart review.团体认知行为分析系统心理治疗(CBASP)治疗持续性抑郁门诊患者:回顾性图表分析。
Br J Clin Psychol. 2020 Nov;59(4):552-564. doi: 10.1111/bjc.12266. Epub 2020 Sep 13.
9
Cognitive behavioral analysis system of psychotherapy versus interpersonal psychotherapy for early-onset chronic depression: a randomized pilot study.认知行为分析系统心理疗法与人际心理疗法治疗早发性慢性抑郁症的随机试验研究。
J Affect Disord. 2011 Mar;129(1-3):109-16. doi: 10.1016/j.jad.2010.08.003. Epub 2010 Sep 6.
10
Overcoming treatment resistance in chronic depression: a pilot study on outcome and feasibility of the cognitive behavioral analysis system of psychotherapy as an inpatient treatment program.克服慢性抑郁症治疗抵抗:认知行为分析系统心理治疗作为住院治疗方案的疗效和可行性的初步研究。
Psychother Psychosom. 2015;84(1):51-6. doi: 10.1159/000369586. Epub 2014 Dec 24.

引用本文的文献

1
Reduction of oxytocin plasma levels in borderline personality disorder and normalization induced by psychotherapies.边缘型人格障碍患者血浆催产素水平的降低及心理治疗诱导的水平正常化。
Psychol Med. 2025 Mar 21;55:e92. doi: 10.1017/S003329172500042X.
2
Oxytocin as a physiological correlate of dyadic music therapy relationships - a randomized crossover pilot study.催产素作为二元音乐治疗关系的生理关联——一项随机交叉试点研究。
Front Behav Neurosci. 2025 Jan 30;18:1504229. doi: 10.3389/fnbeh.2024.1504229. eCollection 2024.
3
Abnormalities of cortical and subcortical spontaneous brain activity unveil mechanisms of disorders of consciousness and prognosis in patients with severe traumatic brain injury.
皮质和皮质下脑自发活动异常揭示了重度创伤性脑损伤患者意识障碍和预后的机制。
Int J Clin Health Psychol. 2024 Oct-Dec;24(4):100528. doi: 10.1016/j.ijchp.2024.100528. Epub 2024 Nov 28.
4
The effects of intranasal oxytocin on the efficacy of psychotherapy for major depressive disorder: a pilot randomized controlled trial.鼻腔内给予催产素对重性抑郁障碍心理治疗疗效的影响:一项先导随机对照试验。
Psychol Med. 2024 Jul;54(9):2122-2132. doi: 10.1017/S0033291724000217. Epub 2024 Mar 6.
5
Oxytocin in the Treatment of Psychiatric Disorders.催产素在精神疾病治疗中的应用
Medeni Med J. 2023 Sep 28;38(3):218-231. doi: 10.4274/MMJ.galenos.2023.13707.
6
Oxytocin as a Biomarker of Differential Effects to SPACE vs. CBT Treatment of Child Anxiety Disorders.催产素作为儿童焦虑症空间疗法与认知行为疗法差异效应的生物标志物。
J Clin Child Adolesc Psychol. 2025 Mar-Apr;54(2):220-228. doi: 10.1080/15374416.2023.2188557. Epub 2023 May 11.
7
Intertwined associations between oxytocin, immune system and major depressive disorder.催产素、免疫系统与重度抑郁症之间的复杂关联。
Biomed Pharmacother. 2023 Jul;163:114852. doi: 10.1016/j.biopha.2023.114852. Epub 2023 May 8.
8
Anxiety and Depression: What Do We Know of Neuropeptides?焦虑与抑郁:我们对神经肽了解多少?
Behav Sci (Basel). 2022 Jul 29;12(8):262. doi: 10.3390/bs12080262.
9
Why Does Psychotherapy Work and for Whom? Hormonal Answers.心理治疗为何有效以及对谁有效?激素方面的答案。
Biomedicines. 2022 Jun 9;10(6):1361. doi: 10.3390/biomedicines10061361.
10
Multiple Aspects of Inappropriate Action of Renin-Angiotensin, Vasopressin, and Oxytocin Systems in Neuropsychiatric and Neurodegenerative Diseases.肾素-血管紧张素、血管加压素和催产素系统在神经精神疾病和神经退行性疾病中的不适当作用的多个方面
J Clin Med. 2022 Feb 9;11(4):908. doi: 10.3390/jcm11040908.